News | Radiation Therapy | November 14, 2025

ZAP Surgical Systems' next generation planning software sets new benchmarks in speed, simplicity, and precision for stereotactic radiosurgery.

ZAP Surgical’s Radiosurgery Planning System Receives FDA 510(k),  E.U. CE Clearance

ZAP-X Gyroscopic Radiosurgery Platform with the integrated ZAP-Axon Radiosurgery Planning System. (Photo: Zap Surgical Systems)


Nov. 11, 2025 — ZAP Surgical Systems recently announced its ZAP-Axon Radiosurgery Planning System has received both U.S. FDA 510(k) clearance and European CE certification. These key regulatory milestones authorize clinical use of ZAP-Axon throughout the United States and European Union, marking a significant advance in the evolution of world-class radiosurgery planning.

Dedicated exclusively to cranial stereotactic radiosurgery (SRS), ZAP-Axon eliminates the time-consuming and cumbersome interfaces of multi-purpose planning software originally developed for full-body applications and diverse radiation delivery techniques. Instead, Axon delivers a focused, intuitive environment where sophisticated data visualization meets seamless usability - empowering clinicians to plan radiosurgery cases with greater efficiency and clarity.

ZAP-Axon was developed in parallel with the company’s ZAP-X® Gyroscopic Radiosurgery platform, enabling seamless integration between planning and delivery for enhanced workflow efficiency and treatment precision.

“By eliminating unnecessary complexity and clutter, Axon’s streamlined interface allows clinicians to quickly master advanced radiosurgery planning - without the complicated navigation common in legacy systems,” said John R. Adler, MD, Professor Emeritus of Neurosurgery at Stanford University and Founder & CEO of ZAP Surgical Systems. “Axon gives clinicians a clean, focused environment where advanced radiosurgery planning becomes second nature.”

Central to Axon’s innovation is a Krylov quadratic optimizer that enhances treatment quality and helps to safeguard critical brain structures by enabling clinicians to rapidly generate and compare multiple candidate plans. What once took 20 minutes can now be achieved in just 30–45 seconds, allowing for far more thorough plan evaluation and refinement.

“As the first system in its field built entirely on modern web technologies, Axon is uniquely positioned to rapidly integrate and fully harness the power of AI,” noted Alex Maslowski, PhD, Vice President of Software at ZAP Surgical. “We’re witnessing the beginning of an entirely new generation in high-precision radiosurgery planning.”

When paired with the ZAP-X platform, Axon enables the full potential of the world’s first and only vault-free, cobalt-free radiosurgery system. ZAP-X utilizes an advanced gyroscopic architecture to deliver thousands of potential non-isocentric beam angles for superior dose conformity and healthy tissue preservation - all without the need for costly shielded treatment bunkers or radioactive sources.

For more information about ZAP Surgical and the ZAP-X system, visit www.zapsurgical.com.


Related Content

News | Computed Tomography (CT)

March 5, 2026 — At ECR 2026, Royal Philips introduced Rembra, its next-generation radiology CT system designed for the ...

Time March 09, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

March 4, 2026 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Bayer for the expanded ...

Time March 04, 2026
arrow
News | Ultrasound Women's Health

March 2, 2026 — Ultrasound AI, a provider of artificial intelligence applications for medical imaging, has received FDA ...

Time March 03, 2026
arrow
News | Remote Viewing Systems

Feb. 26, 2026 — DeepHealth, Inc., a provider of AI-powered health informatics and a wholly owned subsidiary of RadNet ...

Time February 27, 2026
arrow
News | Contrast Media

Feb. 23, 2026 — Bracco, a global leader in diagnostic imaging, recently announced that the U.S. Food and Drug ...

Time February 24, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 19, 2026 — GE HealthCare recently announced 510(k) clearance of three new magnetic resonance (MR) innovations with ...

Time February 20, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Lung Imaging

Feb. 3, 2026 — RevealDx, a leader in the characterization of lung nodules, recently announced FDA clearance of RevealAI ...

Time February 04, 2026
arrow
News | FDA

Jan. 29, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MIM ...

Time February 03, 2026
arrow
Subscribe Now